Flex Pharma Obtains $40,000,000 New Financing Round

  • Feed Type
  • Date
    9/8/2014
  • Company Name
    Flex Pharma
  • Mailing Address
    800 Boylston St. 24th Floor Boston, MA 02199 USA
  • Company Description
    Most muscle cramps are not caused by dehydration, lactic acid, electrolyte imbalance, or muscle tightness. That is why popular remedies like sports drinks, bananas, magnesium tablets, and stretching are usually ineffective. Flex Pharma is developing products to address muscle cramps and spasms by halting repetitive firing of the motor neurons.
  • Website
    http://www.flex-pharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Flex Pharma plans to further advance the science and its clinical candidates addressing neuromuscular disorders with this financing.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy